Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activities. 2012

Sergio A Caldarelli, and Matthieu Hamel, and Jean-Frédéric Duckert, and Mahama Ouattara, and Michèle Calas, and Marjorie Maynadier, and Sharon Wein, and Christian Périgaud, and Alain Pellet, and Henri J Vial, and Suzanne Peyrottes
Institut des Biomolécules Max Mousseron (IBMM), UMR 5247 CNRS-UM1&2, Université Montpellier 2 , cc 1705, place E. Bataillon, 34095 Montpellier, France.

We report herein the design, synthesis, and biological screening of a series of 15 disulfide prodrugs as precursors of albitiazolium bromide (T3/SAR97276, compound 1), a choline analogue which is currently being evaluated in clinical trials (phase II) for severe malaria. The corresponding prodrugs are expected to revert back to the active bis-thiazolium salt through an enzymatic reduction of the disulfide bond. To enhance aqueous solubility of these prodrugs, an amino acid residue (valine or lysine) or a phosphate group was introduced on the thiazolium side chain. Most of the novel derivatives exhibited potent in vitro antimalarial activity against P. falciparum. After oral administration, the cyclic disulfide prodrug 8 showed the best improvement of oral efficacy in comparison to the parent drug.

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Sergio A Caldarelli, and Matthieu Hamel, and Jean-Frédéric Duckert, and Mahama Ouattara, and Michèle Calas, and Marjorie Maynadier, and Sharon Wein, and Christian Périgaud, and Alain Pellet, and Henri J Vial, and Suzanne Peyrottes
September 2011, European journal of medicinal chemistry,
Sergio A Caldarelli, and Matthieu Hamel, and Jean-Frédéric Duckert, and Mahama Ouattara, and Michèle Calas, and Marjorie Maynadier, and Sharon Wein, and Christian Périgaud, and Alain Pellet, and Henri J Vial, and Suzanne Peyrottes
April 2016, Molecules (Basel, Switzerland),
Sergio A Caldarelli, and Matthieu Hamel, and Jean-Frédéric Duckert, and Mahama Ouattara, and Michèle Calas, and Marjorie Maynadier, and Sharon Wein, and Christian Périgaud, and Alain Pellet, and Henri J Vial, and Suzanne Peyrottes
August 1984, Rinsho byori. The Japanese journal of clinical pathology,
Sergio A Caldarelli, and Matthieu Hamel, and Jean-Frédéric Duckert, and Mahama Ouattara, and Michèle Calas, and Marjorie Maynadier, and Sharon Wein, and Christian Périgaud, and Alain Pellet, and Henri J Vial, and Suzanne Peyrottes
February 2010, Journal of agricultural and food chemistry,
Sergio A Caldarelli, and Matthieu Hamel, and Jean-Frédéric Duckert, and Mahama Ouattara, and Michèle Calas, and Marjorie Maynadier, and Sharon Wein, and Christian Périgaud, and Alain Pellet, and Henri J Vial, and Suzanne Peyrottes
January 1994, Chemical & pharmaceutical bulletin,
Sergio A Caldarelli, and Matthieu Hamel, and Jean-Frédéric Duckert, and Mahama Ouattara, and Michèle Calas, and Marjorie Maynadier, and Sharon Wein, and Christian Périgaud, and Alain Pellet, and Henri J Vial, and Suzanne Peyrottes
October 2009, Journal of inorganic biochemistry,
Sergio A Caldarelli, and Matthieu Hamel, and Jean-Frédéric Duckert, and Mahama Ouattara, and Michèle Calas, and Marjorie Maynadier, and Sharon Wein, and Christian Périgaud, and Alain Pellet, and Henri J Vial, and Suzanne Peyrottes
May 1990, Journal of medicinal chemistry,
Sergio A Caldarelli, and Matthieu Hamel, and Jean-Frédéric Duckert, and Mahama Ouattara, and Michèle Calas, and Marjorie Maynadier, and Sharon Wein, and Christian Périgaud, and Alain Pellet, and Henri J Vial, and Suzanne Peyrottes
November 1955, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
Sergio A Caldarelli, and Matthieu Hamel, and Jean-Frédéric Duckert, and Mahama Ouattara, and Michèle Calas, and Marjorie Maynadier, and Sharon Wein, and Christian Périgaud, and Alain Pellet, and Henri J Vial, and Suzanne Peyrottes
December 2005, European journal of medicinal chemistry,
Sergio A Caldarelli, and Matthieu Hamel, and Jean-Frédéric Duckert, and Mahama Ouattara, and Michèle Calas, and Marjorie Maynadier, and Sharon Wein, and Christian Périgaud, and Alain Pellet, and Henri J Vial, and Suzanne Peyrottes
October 2023, European journal of medicinal chemistry,
Copied contents to your clipboard!